Security key
03879J100
Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q3 2017 13F Holders as of 30 Sep 2017
- Security type / class
- Equity / Common Shares, without par value
- Total 13F shares
- 31,250,927
- Total 13F value
- $193,761,084
- Share change
- -5,624,184
- Put/Call ratio
- 54%
- SEC-reported price per share
- $6.20
- Number of holders
- 51
- Value change
- -$33,550,517
- Number of buys
- 25
- Number of sells
- 20
- Shares outstanding
- 197,420,670
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2017
Institutions
51
Top holders
10
ABUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2017
Previous quarter: Q2 2017
Arbutus Biopharma Corp SEC filings
Arbutus Biopharma Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03879J100
Recent filing periods:
Ownership snapshot
Top reported holders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
QVT Financial LP
Disclosed value leader
QVT Financial LP
Comparable rows
15/15
Latest evidence
30 Jun 2017
13F
Lead comparable stake: 8.1%
Showing 1-6 of 15 holder rows.
Quick read
QVT Financial LP leads the comparable SEC ownership view at 8.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens QVT Financial LP's linked filing trail.
Comparable ownership
Top 5
QVT Financial LP
8.1%
LADENBURG THALMANN FINANCIAL SERV...
2.7%
RTW INVESTMENTS, LP
2.6%
PRIMECAP MANAGEMENT CO/CA/
2%
D. E. Shaw & Co., Inc.
0.88%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| QVT Financial LP |
13F
Company
|
8.1%
|
$57,649,000
16,013,540 shares
|
— | 30 Jun 2017 |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
Company
|
2.7%
|
$19,062,000
5,294,945 shares
|
— | 30 Jun 2017 |
| RTW INVESTMENTS, LP |
13F
Company
|
2.6%
|
$18,755,000
5,209,823 shares
|
— | 30 Jun 2017 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
2%
|
$14,221,000
3,950,400 shares
|
— | 30 Jun 2017 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
0.88%
|
$6,244,000
1,734,529 shares
|
— | 30 Jun 2017 |
| BANK OF MONTREAL /CAN/ |
13F
Company
|
0.44%
|
$3,147,000
874,254 shares
|
— | 30 Jun 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
31,250,927
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2017 vs Q2 2017 Across Filers
Q2 2017 holders
45
Q3 2017 holders
51
Holder diff
6
| Investor | Q2 2017 Shares | Q3 2017 Shares | Share Diff | Share Chg % | Q2 2017 value | Q3 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend